CAC
IMMU

Cowen and Company’s Immunomedics Inc IMMU Stock Holding History

Cowen and Company’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-9,051
Closed -$192K – 599
2019
Q4 		$192K Sell
9,051
-28,949
-76% -$511K 0.02% 212
2019
Q3 		$504K Buy
+38,000
New +$559K 0.13% 107

Cowen and Company's IMMU Position: Q1 2020 in Review

Cowen and Company sold out of Immunomedics Inc (IMMU) in Q1 2020, closing a stake of 9,051 shares — an estimated $192K sold.

Cowen and Company first reported a position in IMMU in Q3 2019 and held it in 2 quarters. The position peaked at $504K in Q3 2019. 220 funds tracked by Wall St. Rank hold IMMU as of Q1 2020.

  • Cowen and Company reported no remaining Immunomedics Inc position as of Q1 2020 after selling out during the quarter.
  • Cowen and Company sold 9,051 Immunomedics Inc shares in Q1 2020, an estimated $192K.
  • Cowen and Company first reported a position in Immunomedics Inc in Q3 2019 and held it in 2 quarters.
  • Cowen and Company's Immunomedics Inc position peaked at $504K in Q3 2019.
  • 220 funds tracked by Wall St. Rank held Immunomedics Inc as of Q1 2020.

Based on Cowen and Company's 13F filing for Q1 2020, filed 11 May 2020.